Compound atlas
Metabolic
Semaglutide
Also known as · Ozempic · Wegovy
Half-life
168h
approx. mean t½
Dose range
0.25–2.4 mg / week
typical, not prescriptive
Category
Metabolic
primary use-case
— Overview
A long-acting GLP-1 receptor agonist used for type 2 diabetes and weight management. Slows gastric emptying, suppresses appetite.
— Mechanism of action
Binds GLP-1 receptors. Enhances glucose-dependent insulin secretion, suppresses glucagon, delays gastric emptying.
— Typical protocol
Subcutaneous weekly. Titrate: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg over months.
— Storage
Refrigerated 2–8°C. Once in use, stable at room temp up to 6 weeks.
Disclaimer
This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.